Showing 29,681 - 29,700 results of 29,829 for search '(( 50 ((n decrease) OR (nn decrease)) ) OR ( 20 ((mean decrease) OR (a decrease)) ))', query time: 0.76s Refine Results
  1. 29681

    Image_2_Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study.tif by Zhen Ma (281909)

    Published 2024
    “…GAD also exerted a causal effect on CD27 on IgD-CD38br (β=-0.155,95%CI=0.78~0.94,P=0.002), CD20-%B cell (β= -0.105,95% CI=0.77~0.94, P=0.002), IgD-CD38br%lymphocyte(β=-0.305, 95%CI=0.79~0.95, P=0.002), FSC-A level on granulocytes (β=0.200, 95%CI=0.75~0.91, P=8.35×10<sup>−5</sup>), and CD4RA on TD CD4+(β=-0.150, 95% CI=0.82~1.02, P=0.099). …”
  2. 29682

    Image_3_Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study.tif by Zhen Ma (281909)

    Published 2024
    “…GAD also exerted a causal effect on CD27 on IgD-CD38br (β=-0.155,95%CI=0.78~0.94,P=0.002), CD20-%B cell (β= -0.105,95% CI=0.77~0.94, P=0.002), IgD-CD38br%lymphocyte(β=-0.305, 95%CI=0.79~0.95, P=0.002), FSC-A level on granulocytes (β=0.200, 95%CI=0.75~0.91, P=8.35×10<sup>−5</sup>), and CD4RA on TD CD4+(β=-0.150, 95% CI=0.82~1.02, P=0.099). …”
  3. 29683

    Image_1_Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study.tif by Zhen Ma (281909)

    Published 2024
    “…GAD also exerted a causal effect on CD27 on IgD-CD38br (β=-0.155,95%CI=0.78~0.94,P=0.002), CD20-%B cell (β= -0.105,95% CI=0.77~0.94, P=0.002), IgD-CD38br%lymphocyte(β=-0.305, 95%CI=0.79~0.95, P=0.002), FSC-A level on granulocytes (β=0.200, 95%CI=0.75~0.91, P=8.35×10<sup>−5</sup>), and CD4RA on TD CD4+(β=-0.150, 95% CI=0.82~1.02, P=0.099). …”
  4. 29684

    Table_2_Causal role of immune cells in generalized anxiety disorder: Mendelian randomization study.xlsx by Zhen Ma (281909)

    Published 2024
    “…GAD also exerted a causal effect on CD27 on IgD-CD38br (β=-0.155,95%CI=0.78~0.94,P=0.002), CD20-%B cell (β= -0.105,95% CI=0.77~0.94, P=0.002), IgD-CD38br%lymphocyte(β=-0.305, 95%CI=0.79~0.95, P=0.002), FSC-A level on granulocytes (β=0.200, 95%CI=0.75~0.91, P=8.35×10<sup>−5</sup>), and CD4RA on TD CD4+(β=-0.150, 95% CI=0.82~1.02, P=0.099). …”
  5. 29685

    Optimizing replay intensity and resolution in aberration-compensated off-axis holograms by ambient humidity control by Henry Nebrensky (1229277)

    Published 2019
    “…However this means that the Bragg condition may no longer be satisfied during replay, reducing the diffraction efficiency and decreasing the SNR of the reconstructed images. …”
  6. 29686

    DataSheet13_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  7. 29687

    DataSheet10_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  8. 29688

    Presentation1_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  9. 29689

    Image7_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  10. 29690

    DataSheet7_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  11. 29691

    Presentation3_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  12. 29692

    Image14_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  13. 29693

    DataSheet6_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  14. 29694

    Image1_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.TIF by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  15. 29695

    DataSheet12_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  16. 29696

    DataSheet9_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  17. 29697

    Presentation6_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.PPTX by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  18. 29698

    Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes by Nivedita Hegdekar (6563744)

    Published 2023
    “…Our data also demonstrated a role for precision autophagy in targeting and degradation of innate immune pathways components, such as the NLRP3 inflammasome. …”
  19. 29699

    DataSheet8_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”
  20. 29700

    DataSheet4_Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways.ZIP by Mi Zhou (9884)

    Published 2024
    “…<p>Background: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a common respiratory disease characterized by persistent hypoxemia and an uncontrolled inflammatory response. …”